Circadin
A short-term treatment of primary insomnia* in patients aged 55 years or over.
*Primary insomnia is insomnia without an underlying medical cause or any other clear cause.
- Specifically designed prolonged release melatonin that mimics the body's natural night time melatonin levels1
- The sleep promoting effect will take place from 1-2 hours after taking a tablet2
- Helps you fall asleep, maintain sleep, improve sleep quality and morning alertness1.
ASK YOUR PHARMACIST ABOUT THIS PRODUCT.
1.Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N. Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin. 2007 Oct;23(10):2597-605. 2.CIRCADIN Product Information.


Ghana-Kama
Kenya-Beta Healthcare
MAURITIUS
South Africa-FCC
South Africa-HOLDINGS
South Africa-Pharmacare
Tanzania-Shelys
Canada
China
Malaysia
Philippines
France
Germany
Netherlands
Netherlands-Aspen API
Russia 